• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[伴有双重癌症的凝血因子V抑制剂]

[Factor V inhibitor with double cancer].

作者信息

Okajima A, Horii J, Nasu K, Niki Y, Akasaka K, Yamashita H, Sugimoto M, Yoshioka A

出版信息

Rinsho Ketsueki. 1989 Apr;30(4):514-9.

PMID:2769972
Abstract

A 84-year-old man was admitted with palpitation, edema of legs and anemia during a long course of diabetes mellitus, prostatic hypertrophy and prostatic cancer. He revealed purpura on the hands and massive microhematuria. He had received antibiotic therapy for a urinary tract infection for a period of time, but he had no history of hemorrhagic tendency or blood transfusion. Coagulation studies showed the prolongation of whole blood clotting time and PT (prothrombin time). Activity of factor V was 14% of that normal control plasma. The titer of factor V inhibitor was 4.9 Bethesda units/ml. The inhibitor of the patient was supposed to belong to IgA and IgG judging from inhibitor neutralization test. PT was improved after discontinuance of administration of antibiotics and administration of azathioprine. Moreover, even after administration of prednisolone with antibiotics, PT and activity of factor V recovered to normal range. He died from respiratory failure. Autopsy revealed double cancer of prostate and descending colon. The appearance of factor V inhibitor was likely caused by antibiotics, double cancer, and age-related immune disorders.

摘要

一名84岁男性因长期患有糖尿病、前列腺肥大和前列腺癌,出现心悸、腿部水肿和贫血而入院。他双手出现紫癜并伴有大量镜下血尿。他曾接受过一段时间的抗生素治疗以治疗尿路感染,但他没有出血倾向或输血史。凝血研究显示全血凝血时间和PT(凝血酶原时间)延长。因子V活性为正常对照血浆的14%。因子V抑制剂滴度为4.9贝塞斯达单位/毫升。根据抑制剂中和试验判断,患者的抑制剂应属于IgA和IgG。停用抗生素并给予硫唑嘌呤后,PT有所改善。此外,即使在使用泼尼松龙联合抗生素治疗后,PT和因子V活性也恢复到正常范围。他死于呼吸衰竭。尸检发现前列腺和降结肠双癌。因子V抑制剂的出现可能是由抗生素、双癌以及年龄相关的免疫紊乱引起的。

相似文献

1
[Factor V inhibitor with double cancer].[伴有双重癌症的凝血因子V抑制剂]
Rinsho Ketsueki. 1989 Apr;30(4):514-9.
2
[Simultaneous development of factor V inhibitor and autoimmune thrombocytopenia in a patient with dermatomyositis].
Rinsho Ketsueki. 2002 Dec;43(12):1050-4.
3
[High-titer idiopathic acquired factor V inhibitor patient showing decreased activities of multiple coagulation factors].[高滴度特发性获得性因子V抑制剂患者出现多种凝血因子活性降低]
Rinsho Ketsueki. 2008 Jun;49(6):413-6.
4
[A long-lasting idiopathic factor V inhibitor].[一种持续性特发性因子V抑制剂]
Rinsho Ketsueki. 2003 Jan;44(1):14-8.
5
[Clinical cases of acquired coagulation inhibitors].[获得性凝血抑制剂的临床病例]
Rinsho Byori. 2000 Dec;48(12):1093-101.
6
[A case positive for the inhibitor for coagulation factor V].[一例凝血因子V抑制剂阳性病例]
Rinsho Byori. 1999 Oct;47(10):971-5.
7
[Acquired inhibitor against coagulation factor V with severe hematuria].[获得性凝血因子V抑制物伴严重血尿]
Rinsho Ketsueki. 2003 Sep;44(9):933-9.
8
[Fatal opportunistic infection following disappearance of antibodies by immunosuppressive therapy in a patient with acquired factor VIII inhibitor].[一名获得性因子VIII抑制剂患者接受免疫抑制治疗后抗体消失,继而发生致命性机会性感染]
Rinsho Ketsueki. 2004 Sep;45(9):1023-7.
9
Factor V inhibitor associated with immune complex formation.与免疫复合物形成相关的凝血因子V抑制剂。
Arch Pathol Lab Med. 1986 May;110(5):448-51.
10
[Anesthetic management of a patient with acquired factor V inhibitor].[获得性凝血因子V抑制剂患者的麻醉管理]
Masui. 2010 Nov;59(11):1423-7.

引用本文的文献

1
Acquired factor V inhibitors: a systematic review.获得性因子 V 抑制剂:系统评价。
J Thromb Thrombolysis. 2011 May;31(4):449-57. doi: 10.1007/s11239-010-0529-6.
2
Rapid elimination of a high-titer spontaneous factor V antibody by extracorporeal antibody-based immunoadsorption and immunosuppression.通过基于抗体的体外免疫吸附和免疫抑制快速清除高滴度自发性因子V抗体。
Ann Hematol. 1995 Oct;71(4):199-203. doi: 10.1007/BF01910319.